Search filters

List of works by Russel T Burge

Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis

scientific article published on 01 October 2019

Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study

scientific article published on 01 March 2019

Comparison of Health Care Costs Among Patients with Psoriasis Initiating Ixekizumab, Secukinumab, or Adalimumab

scientific article published on 01 December 2019

Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab

scientific article published on 09 March 2020

Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis

scientific article published on 26 December 2019

Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab

scientific article published on 08 November 2019

Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis

scientific article published in December 2017

Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis

scientific article published on 22 August 2017

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review

scientific article published on 01 January 2021

Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses

scientific article published on 15 July 2019

Efficacy and Safety of Ixekizumab Over 4 Years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis.

scientific article published on 10 April 2018

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials

scientific article published on 21 March 2020

Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial

scientific article published on 18 March 2019

Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study

scientific article published on 01 November 2018

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis

scientific article published on 26 October 2019

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review

scholarly article by Mwangi J Murage et al published 2018 in Patient Preference and Adherence

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia

scientific article published on 23 June 2020

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses

scientific article published on 04 November 2019

Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization

scientific article published on 28 June 2018

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)

scientific article published on 10 September 2020

Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis

scientific article published on 10 October 2019

The experience of itch in children with psoriasis: A qualitative exploration of the Itch Numeric Rating Scale

scientific article published on 18 December 2020

Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey

scientific article published on 19 October 2019